At first glance, the data coming out of eastern France appears alarming: the number of cancer cases in the Bas-Rhin department has increased by a factor of 2.5 since the mid-1970s. However, for public health experts, this surge does not signal a localized crisis, but rather a reflection of broader national trends and the success of modern medicine.
According to a recent study by the Ligue contre le cancer, the annual number of cases recorded between 1975 and 1979 stood at 2,896. By the 2020-2021 period, that figure had climbed to 7,030 per year. While the raw increase is steep, the trend mirrors the experience of the rest of the country, suggesting that cancer rates in Bas-Rhin are no longer higher than in other regions of France.
As a physician, I find this distinction critical. In oncology, an increase in recorded cases often tells two stories simultaneously: one of rising risk and another of improved detection. When we see numbers climb, It’s rarely due to a single cause, but rather a confluence of demographic shifts and the evolving precision of our diagnostic tools.
| Period | Average Annual Cases |
|---|---|
| 1975–1979 | 2,896 |
| 2020–2021 | 7,030 |
The disappearance of the “Alsatian anomaly”
For decades, the Alsace region was viewed through a specific epidemiological lens. Roughly 30 years ago, the region exhibited a notably higher prevalence of colorectal cancers compared to the national average. At the time, medical professionals attributed this disparity to regional dietary habits—specifically a diet rich in meats and traditional charcuterie.
Professor Simon Schraub, who leads prevention efforts for the Ligue contre le cancer du Bas-Rhin, notes that this regional specificity has largely vanished. He explains that the latest data shows that, fortunately, there are no more cancers in Alsace than in the general French population.
This shift suggests a stabilization of dietary risks or a convergence of eating habits across France, meaning the “Alsatian anomaly” has been replaced by a shared national health profile. The drivers of cancer in the region have shifted from local cultural habits to global lifestyle and biological factors.
Demographics, tobacco, and the screening paradox
If diet is no longer the primary differentiator, what is driving the 2.5-fold increase in cases? The answer lies in a combination of biology and behavior. The most significant factor is the aging of the population; cancer is fundamentally a disease of cellular aging, and as the average lifespan increases, so does the cumulative risk of developing a malignancy.
Beyond aging, population growth in the region naturally increases the absolute number of cases. However, behavioral risks remain a persistent challenge. Professor Schraub specifically highlights the impact of carcinogens, pointing to tobacco leverage—particularly the rise of smoking among women—as a key driver of current trends.
There is also the “screening paradox.” The increase in numbers is partially a sign of medical success. The development of early diagnosis and more aggressive screening programs means that cancers are being caught earlier and more frequently. Cases that would have gone undetected or been diagnosed only at the terminal stage in 1975 are now captured in the registry at an early, treatable stage.
A gold mine of longitudinal data
The ability to track these changes with such precision is due to a unique local asset: the Bas-Rhin cancer registry. What we have is the oldest cancer registry in France, providing a longitudinal dataset that is virtually unmatched in its duration and consistency.
Philippe Bergerot, president of the Ligue nationale contre le cancer, emphasizes that this long-term tracking allows health officials to identify exactly which types of cancer are rising and among which populations. This granular data has revealed specific increases in breast and lung cancers among women, allowing for more targeted public health interventions.
Robert Herrmann, president of the committee for the Ligue contre le cancer du Bas-Rhin, noted that the region’s pioneering approach to data collection has set a precedent that is now being adopted on a national scale across France. By documenting the journey from dietary-linked cancers to aging-linked cancers, the Bas-Rhin registry serves as a blueprint for how regional data can inform national policy.
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
The focus now shifts to the neighboring department. A similar comprehensive study is currently underway in the Haut-Rhin, with results expected to be released this autumn. These findings will determine if the trends seen in Bas-Rhin are consistent across the entire Alsace region.
We invite you to share this report and join the conversation in the comments below regarding regional health trends and the importance of early screening.
Keep reading
